Table 1.
Overview of samples used in this study.
| Gender | Age | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| HP* Status | n (Total) | Female | Male | Female + Male | Female | Male | |||
| n | % | n | % | ||||||
| negative | 63 | 33 | 52.4 | 30 | 47.6 | 53.6 ± 13.3 | 53.8 ± 14.2 | 53.3 ± 12.2 | |
| positive (total) | 139 | 73 | 52.5 | 66 | 47.5 | 55.1 ± 14.9 | 56.8 ± 15.4 | 53.2 ± 14.0 | |
| asymptomatic | 66 | 34 | 51.5 | 32 | 48.5 | 55.2 ± 15.1 | 58.9 ± 14.6 | 53.0 ± 14.0 | |
| atrophy | 18 | 11 | 61.1 | 7 | 38.9 | 55.1 ± 13.6 | 54.1 ± 13.0 | 56.7 ± 14.4 | |
| intestinal metaplasia | 41 | 20 | 48.8 | 21 | 51.2 | 54.7 ± 13.7 | 57.6 ± 12.1 | 51.9 ± 14.5 | |
| ulcer | 14 | 8 | 57.1 | 6 | 42.9 | 55.6 ± 18.3 | 56.4 ± 22.4 | 54.5 ± 10.7 | |
| eradicated | 63 | 32 | 50.8 | 31 | 49.2 | 56.3 ± 13.5 | 57.4 ± 14.5 | 55.2 ± 12.4 | |
* HP = H. pylori.